Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 21-30 of 45

Page
per page
  1. SP 600125
    A4604 SP 600125
     7 Citation
    Target: JNK
    Summary: JNK1/2/3 inhibitor
      insoluble in H2O; ≥11 mg/mL
  2. MEK inhibitor
    A3594 MEK inhibitor
    Summary: Potent MEK inhibitor, Antitumor agent
      Soluble in DMSO
  3. PKA inhibitor fragment (6-22) amide
    A1117 PKA inhibitor fragment (6-22) amide
    Summary: PKA inhibitor
      ≥186.8 mg/mL
  4. AS 602801
    A3189 AS 602801
    Summary: Jun Kinase Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
  5. SCH772984 TFA
    B5867 SCH772984 TFA
    Summary: ERK1/2 inhibitor
      ≥26.1 mg/mL
  6. SCH772984 HCl
    B5866 SCH772984 HCl
    Summary: ERK1/2 inhibitor
      ≥23.5 mg/mL
  7. PD 184161
    C4361 PD 184161
    Summary: MEK1/2 inhibitor
      ≤10 mg/mL
  8. PD 198306
    B7124 PD 198306
    Summary: MEK1/2 inhibitor
      Soluble in DMSO
  9. Ulixertinib (hydrochloride)
    C3921 Ulixertinib (hydrochloride)
    Summary: reversible ERK1/2 inhibitor
      insoluble in H2O; ≥20.15 mg/mL
  10. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL

Items 21-30 of 45

Page
per page